Literature DB >> 17365769

Gender differences relative to smoking behavior and emissions of toxins from mainstream cigarette smoke.

Assieh A Melikian1, Mirjana V Djordjevic, James Hosey, Jie Zhang, Shuquan Chen, Edith Zang, Joshua Muscat, Steven D Stellman.   

Abstract

This study examined whether gender differences exist in the exposure to select mainstream cigarette smoke toxins as a result of differences in smoking behavior or type of cigarettes smoked among 129 female and 128 male smokers. Smoking topography data indicated that, compared with men, women took smaller puffs (37.6 ml/puff vs. 45.8 ml/puff; p = .0001) of shorter duration (1.33 s/puff vs. 1.48 s/puff; p = .002) but drew more puffs per cigarette (13.5 vs. 12.0; p = .001) and left longer butts (36.3 mm or 40.2% of cigarette length vs. 34.3 mm or 39.2% of cigarette length; p = .01). These trends were similar in both African Americans and European Americans. The emissions of select toxins per cigarette, as determined by mimicking human smoking behaviors were greater among the male smokers than the female smokers and correlated significantly with delivered smoke volume per cigarette. The geometric means of emissions of nicotine from cigarettes were 1.92 mg/cigarette (95% CI = 1.80-2.05) for women versus 2.20 (95% CI = 2.04-2.37) for men (p = .005). Cigarettes smoked by women yielded 139.5 ng/cigarette of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK; 95% CI = 128.8-151.0), compared with 170.3 ng/cigarette (95% CI = 156.3-185.6) for men (p = .0007); benzo(a)pyrene (BaP) emissions were 18.0 ng/cigarette (95% CI = 17.0-19.0) for women and 20.5 ng/cigarette (95% CI = 18.8-22.3) for men (p = .01). The gender differences with regard to cigarette smoke yields of toxins were more profound in European Americans than in African Americans. On average, African American men's smoking habits produced the highest emissions of select toxins from cigarettes, and European American female smokers had the lowest exposure to carcinogens and toxins. Several studies have suggested that women may be more susceptible than men to the ill effects of carcinogens in tobacco and tobacco smoke, whereas other studies have not found differences in lung cancer risk between men and women. The present study suggests that gender differences in exposure to tobacco smoke cannot account for a higher rate of lung cancer in female smokers compared with male smokers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17365769     DOI: 10.1080/14622200701188836

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  31 in total

1.  Gender differences in cigarette smoking, social correlates and cessation among adolescents.

Authors:  Steven A Branstetter; John Blosnich; Geri Dino; Jill Nolan; Kimberly Horn
Journal:  Addict Behav       Date:  2012-02-23       Impact factor: 3.913

2.  Differential success rates in racial groups: results of a clinical trial of smoking cessation among female prisoners.

Authors:  Karen L Cropsey; Michael F Weaver; Gloria D Eldridge; Gabriela C Villalobos; Al M Best; Maxine L Stitzer
Journal:  Nicotine Tob Res       Date:  2009-04-22       Impact factor: 4.244

3.  Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers.

Authors:  Daniel J O Roche; Spencer Bujarski; Emily Hartwell; ReJoyce Green; Lara A Ray
Journal:  Pharmacol Biochem Behav       Date:  2015-04-28       Impact factor: 3.533

Review 4.  Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco.

Authors:  Michael D Johnson; Jodi Schilz; Mirjana V Djordjevic; Jerry R Rice; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

5.  CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populations.

Authors:  Catherine A Wassenaar; Yuanqing Ye; Qiuyin Cai; Melinda C Aldrich; Joanne Knight; Margaret R Spitz; Xifeng Wu; William J Blot; Rachel F Tyndale
Journal:  Carcinogenesis       Date:  2014-11-21       Impact factor: 4.944

6.  Assessing exposure to tobacco-specific carcinogen NNK using its urinary metabolite NNAL measured in US population: 2011-2012.

Authors:  Binnian Wei; Benjamin C Blount; Baoyun Xia; Lanqing Wang
Journal:  J Expo Sci Environ Epidemiol       Date:  2015-01-07       Impact factor: 5.563

7.  Exogenous progesterone for smoking cessation in men and women: a pilot double-blind, placebo-controlled randomized clinical trial.

Authors:  Nicole L Tosun; Ann M Fieberg; Lynn E Eberly; Katherine A Harrison; Angela R Tipp; Alicia M Allen; Sharon S Allen
Journal:  Addiction       Date:  2019-06-17       Impact factor: 6.526

8.  Gender and stimulus control of smoking behavior.

Authors:  Stuart G Ferguson; Mai Frandsen; Michael S Dunbar; Saul Shiffman
Journal:  Nicotine Tob Res       Date:  2015-04       Impact factor: 4.244

Review 9.  Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies.

Authors:  Catalin Marian; Richard J O'Connor; Mirjana V Djordjevic; Vaughan W Rees; Dorothy K Hatsukami; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

10.  Utility and relationships of biomarkers of smoking in African-American light smokers.

Authors:  Man Ki Ho; Babalola Faseru; Won S Choi; Nicole L Nollen; Matthew S Mayo; Janet L Thomas; Kolawole S Okuyemi; Jasjit S Ahluwalia; Neal L Benowitz; Rachel F Tyndale
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.